{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:57:52Z","timestamp":1792083472913,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00448"],"award-info":[{"award-number":["PI20\/00448"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PDI2019-105837RB-I00"],"award-info":[{"award-number":["PDI2019-105837RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018-098515-B-I00"],"award-info":[{"award-number":["RTI2018-098515-B-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201821-31"],"award-info":[{"award-number":["201821-31"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007652","name":"Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria","doi-asserted-by":"publisher","award":["INIA-FPI-SGIT-2015-02"],"award-info":[{"award-number":["INIA-FPI-SGIT-2015-02"]}],"id":[{"id":"10.13039\/100007652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      More than 40 pathogenic heterozygous\n                      <jats:italic>PRNP<\/jats:italic>\n                      mutations causing inherited prion diseases have been identified to date. Recessive inherited prion disease has not been described to date.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We describe the clinical and neuropathological data of inherited early-onset prion disease caused by the rare\n                      <jats:italic>PRNP<\/jats:italic>\n                      homozygous mutation R136S. In vitro PrP\n                      <jats:sup>Sc<\/jats:sup>\n                      propagation studies were performed using recombinant-adapted protein misfolding cyclic amplification technique. Brain material from two R136S homozygous patients was intracranially inoculated in TgMet129 and TgVal129 transgenic mice to assess the transmissibility of this rare inherited form of prion disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The index case presented symptoms of early-onset dementia beginning at the age of 49 and died at the age of 53. Neuropathological evaluation of the proband revealed abundant multicentric PrP plaques and Western blotting revealed a ~ 8 kDa protease-resistant, unglycosylated PrP\n                      <jats:sup>Sc<\/jats:sup>\n                      fragment, consistent with a Gerstmann-Str\u00e4ussler-Scheinker phenotype. Her youngest sibling suffered from progressive cognitive decline, motor impairment, and myoclonus with onset in her late 30s and died at the age of 48. Genetic analysis revealed the presence of the R136S mutation in homozygosis in the two affected subjects linked to homozygous methionine at codon 129. One sibling carrying the heterozygous R136S mutation, linked to homozygous methionine at codon 129, is still asymptomatic at the age of 74. The inoculation of human brain homogenates from our index case and an independent case from a Portuguese family with the same mutation in transgenic mice expressing human PrP and in vitro propagation of PrP\n                      <jats:sup>Sc<\/jats:sup>\n                      studies failed to show disease transmissibility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, biallelic R136S substitution is a rare variant that produces inherited early-onset human prion disease with a Gerstmann-Str\u00e4ussler-Scheinker neuropathological and molecular signature. Even if the R136S variant is predicted to be \u201cprobably damaging\u201d, heterozygous carriers are protected, at least from an early onset providing evidence for a potentially recessive pattern of inheritance in human prion diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00912-6","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T23:18:58Z","timestamp":1643584738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Teresa","family":"Ximelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Mar\u00edn-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasier","family":"Era\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge M.","family":"Charco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Riveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonz\u00e1lez-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iban","family":"Aldecoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Molina-Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Mar\u00eda","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7750-896X","authenticated-orcid":false,"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"912_CR1","first-page":"1016","volume-title":"Greenfield\u2019s neuropathology","author":"MW Head","year":"2015","unstructured":"Head MW, Ironside JW, Ghetti B, et al. Prion diseases. In: Love S, Budka H, Ironside JW, Perry A, editors. Greenfield\u2019s neuropathology. 9th ed. Boca Raton: CRC Press; 2015. p. 1016\u201386.","edition":"9"},{"issue":"4","key":"912_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"H Budka","year":"1995","unstructured":"Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5(4):459\u201366. https:\/\/doi.org\/10.1111\/j.1750-3639.1995.tb00625.x PMID: 8974629.","journal-title":"Brain Pathol"},{"issue":"322","key":"912_CR3","doi-asserted-by":"publisher","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","volume":"8","author":"EV Minikel","year":"2016","unstructured":"Minikel EV, Vallabh SM, Lek M, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8(322):322ra9. https:\/\/doi.org\/10.1126\/scitranslmed.aad5169 PMID: 26791950; PMCID: PMC4774245.","journal-title":"Sci Transl Med"},{"issue":"2","key":"912_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166\u201374. https:\/\/doi.org\/10.1007\/s00439-005-0020-1 Epub 2005 Nov 15. PMID: 16187142.","journal-title":"Hum Genet"},{"key":"912_CR5","unstructured":"Kov\u00e1cs GG. Genetic background of human prion diseases. Ideggyogyaszati Szemle; 2007;60(11-12):438\u201346 Hungarian. PMID: 18198790."},{"issue":"8","key":"912_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/NEN.0b013e3181e85737","volume":"69","author":"A Alzualde","year":"2010","unstructured":"Alzualde A, Indakoetxea B, Ferrer I, et al. A novel PRNP Y218N mutation in Gerstmann-Str\u00e4ussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol. 2010;69(8):789\u2013800. https:\/\/doi.org\/10.1097\/NEN.0b013e3181e85737 PMID: 20613639.","journal-title":"J Neuropathol Exp Neurol"},{"key":"912_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/bs.pmbts.2017.06.011","volume-title":"Progress in molecular biology and translational science","author":"DL Ritchie","year":"2017","unstructured":"Ritchie DL. Chapter fourteen - neuropathology of human prion diseases. In: Legname G, Vanni S, editors. Progress in molecular biology and translational science, vol. 150: Academic; 2017. p. 319\u201339. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.06.011. Epub 2017 Aug 3. PMID: 28838666."},{"issue":"5","key":"912_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ana.410200507","volume":"20","author":"P Brown","year":"1986","unstructured":"Brown P, Cathala F, Castaigne P, et al. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol. 1986;20(5):597\u2013602. https:\/\/doi.org\/10.1002\/ana.410200507 PMID: 3539001.","journal-title":"Ann Neurol"},{"issue":"3","key":"912_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s004390050204","volume":"98","author":"O Windl","year":"1996","unstructured":"Windl O, Dempster M, Estibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet. 1996;98(3):259\u201364. https:\/\/doi.org\/10.1007\/s004390050204 PMID: 8707291.","journal-title":"Hum Genet"},{"issue":"2","key":"912_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U","volume":"47","author":"ES Simon","year":"2000","unstructured":"Simon ES, Kahana E, Chapman J, et al. Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation. Ann Neurol. 2000;47(2):257\u201360 PMID: 10665501.","journal-title":"Ann Neurol"},{"issue":"7","key":"912_CR11","doi-asserted-by":"publisher","first-page":"E1551","DOI":"10.1002\/humu.21281","volume":"31","author":"JA Beck","year":"2010","unstructured":"Beck JA, Poulter M, Campbell TA, et al. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC prion unit. Hum Mutat. 2010;31(7):E1551\u201363. https:\/\/doi.org\/10.1002\/humu.21281 PMID: 20583301.","journal-title":"Hum Mutat"},{"key":"912_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4161\/19336896.2014.971569","volume":"8","author":"J Komatsu","year":"2014","unstructured":"Komatsu J, Sakai K, Hamaguchi T, et al. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene. Prion. 2014;8:336\u20138. https:\/\/doi.org\/10.4161\/19336896.2014.971569 PMID: 25495585; PMCID: PMC4601383.","journal-title":"Prion"},{"issue":"8","key":"912_CR13","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00415-020-09826-z","volume":"267","author":"Z Nitsan","year":"2020","unstructured":"Nitsan Z, Cohen OS, Chapman J, et al. Familial Creutzfeldt-Jakob disease homoasanteasantzygous to the E200K mutation: clinical characteristics and disease course. J Neurol. 2020;267(8):2455\u20138. https:\/\/doi.org\/10.1007\/s00415-020-09826-z Epub 2020 May 4. PMID: 32367297.","journal-title":"J Neurol"},{"key":"912_CR14","unstructured":"Pacheco P, Orge L, Head H, et al. Novel prion disease mutation R136S has an incomplete penetrance dependent upon codon 129 trans allele. Prion 2006. Abstract book. Neuroprion https:\/\/www.neuroprion.org\/ (available upon request). In: Strategies, advances and trends towards protection of society."},{"key":"912_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1468-1331.2004.00967.x","volume":"11","author":"R Sanchez-Valle","year":"2004","unstructured":"Sanchez-Valle R, Nos C, Yag\u00fce J, et al. Clinical and genetic features of human prion diseases in Catalonia. Eur J Neurol. 2004;11:649\u201355. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00967.x PMID: 15469448.","journal-title":"Eur J Neurol"},{"issue":"7","key":"912_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381. https:\/\/doi.org\/10.1038\/nprot.2009.86 Epub 2009 Jun 25. PMID: 19561590.","journal-title":"Nat Protoc"},{"issue":"4","key":"912_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, et al. Nat Methods. 2010;7(4):248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-248 PMID: 20354512; PMCID: PMC2855889.","journal-title":"Nat Methods"},{"issue":"4","key":"912_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, de Boni L, Saverioni D, et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol. 2012;124(4):517\u201329. https:\/\/doi.org\/10.1007\/s00401-012-1002-8 Epub 2012 Jun 30. PMID: 22744790; PMCID: PMC3725314.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"912_CR19","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1038\/s41598-017-09489-3","volume":"7","author":"SR Elezgarai","year":"2017","unstructured":"Elezgarai SR, Fern\u00e1ndez-Borges N, Era\u00f1a H, et al. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Str\u00e4ussler-Scheinker syndrome. Sci Rep. 2017;7(1):9584. https:\/\/doi.org\/10.1038\/s41598-017-09489-3 PMID: 28851967; PMCID: PMC5575253.","journal-title":"Sci Rep"},{"issue":"2","key":"912_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneumeth.2007.06.005","volume":"165","author":"C Lund","year":"2007","unstructured":"Lund C, Olsen CM, Tveit H, Tranulis MA. Characterization of the prion protein 3F4 epitope and its use as a molecular tag. J Neurosci Methods. 2007;165(2):183\u201390. https:\/\/doi.org\/10.1016\/j.jneumeth.2007.06.005 Epub 2007 Jun 13. PMID: 17644183.","journal-title":"J Neurosci Methods"},{"issue":"3","key":"912_CR21","doi-asserted-by":"publisher","first-page":"e1001319","DOI":"10.1371\/journal.ppat.1001319","volume":"7","author":"D Padilla","year":"2011","unstructured":"Padilla D, B\u00e9ringue V, Espinosa JC, et al. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog. 2011;7(3):e1001319. https:\/\/doi.org\/10.1371\/journal.ppat.1001319 Epub 2011 Mar 17. PMID: 21445238; PMCID: PMC3060172.","journal-title":"PLoS Pathog"},{"issue":"12","key":"912_CR22","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3201\/eid2012.140548","volume":"20","author":"S Notari","year":"2014","unstructured":"Notari S, Xiao X, Espinosa JC, et al. Transmission characteristics of variably protease-sensitive prionopathy. Emerg Infect Dis. 2014;20(12):2006\u201314. https:\/\/doi.org\/10.3201\/eid2012.140548 PMID: 25418590; PMCID: PMC4257788.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"912_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13567-016-0380-7","volume":"47","author":"P Aguilar-Calvo","year":"2016","unstructured":"Aguilar-Calvo P, Espinosa JC, Andr\u00e9oletti O, et al. Goat K222-PrPC polymorphic variant does not provide resistance to atypical scrapie in transgenic mice. Vet Res. 2016;47(1):96. https:\/\/doi.org\/10.1186\/s13567-016-0380-7 PMID: 27659200; PMCID: PMC5034450.","journal-title":"Vet Res"},{"issue":"1","key":"912_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2353\/ajpath.2006.050766","volume":"168","author":"HM Yull","year":"2006","unstructured":"Yull HM, Ritchie DL, Langeveld JP, et al. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol. 2006;168(1):151\u20137. https:\/\/doi.org\/10.2353\/ajpath.2006.050766 PMID: 16400018; PMCID: PMC1592651.","journal-title":"Am J Pathol"},{"issue":"12","key":"912_CR25","doi-asserted-by":"publisher","first-page":"11247","DOI":"10.1074\/jbc.M407006200","volume":"280","author":"C F\u00e9raudet","year":"2005","unstructured":"F\u00e9raudet C, Morel N, Simon S, et al. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem. 2005;280(12):11247\u201358. https:\/\/doi.org\/10.1074\/jbc.M407006200 Epub 2004 Dec 23. PMID: 15618225.","journal-title":"J Biol Chem"},{"issue":"4","key":"912_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0021-9975(78)90010-5","volume":"88","author":"H Fraser","year":"1978","unstructured":"Fraser H, Dickinson AG. Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol. 1978;88(4):563\u201373. https:\/\/doi.org\/10.1016\/0021-9975(78)90010-5 PMID: 101558.","journal-title":"J Comp Pathol"},{"issue":"1","key":"912_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12883-021-02274-w","volume":"21","author":"A Hassan","year":"2021","unstructured":"Hassan A, Campbell T, Darwent L, et al. Case report of homozygous E200D mutation of PRNP in apparently sporadic Creutzfeldt-Jakob disease. BMC Neurol. 2021;21(1):248. https:\/\/doi.org\/10.1186\/s12883-021-02274-w Published 2021 Jun 28.","journal-title":"BMC Neurol"},{"key":"912_CR28","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/ncomms6821","volume":"5","author":"H Cassard","year":"2014","unstructured":"Cassard H, Torres JM, Lacroux C, et al. Evidence for zoonotic potential of ovine scrapie prions. Nat Commun. 2014;5:5821. https:\/\/doi.org\/10.1038\/ncomms6821 PMID: 25510416.","journal-title":"Nat Commun"},{"issue":"9","key":"912_CR29","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3201\/eid2309.161948","volume":"23","author":"N Fern\u00e1ndez-Borges","year":"2017","unstructured":"Fern\u00e1ndez-Borges N, Espinosa JC, Mar\u00edn-Moreno A, et al. Protective effect of Val129-PrP against bovine spongiform encephalopathy but not variant Creutzfeldt-Jakob disease. Emerg Infect Dis. 2017;23(9):1522\u201330. https:\/\/doi.org\/10.3201\/eid2309.161948 PMID: 28820136; PMCID: PMC5572891.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"912_CR30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3201\/eid2606.181790","volume":"26","author":"A Mar\u00edn-Moreno","year":"2020","unstructured":"Mar\u00edn-Moreno A, Huor A, Espinosa JC, et al. Radical change in zoonotic abilities of atypical BSE prion strains as evidenced by crossing of sheep species barrier in transgenic mice. Emerg Infect Dis. 2020;26(6):1130\u20139. https:\/\/doi.org\/10.3201\/eid2606.181790 PMID: 32441630; PMCID: PMC7258450.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"912_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510x(92)90067-u","volume":"111","author":"LG Goldfarb","year":"1992","unstructured":"Goldfarb LG, Brown P, Vrbovsk\u00e1 A, et al. An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Str\u00e4ussler-Scheinker family. J Neurol Sci. 1992;111(2):189\u201394. https:\/\/doi.org\/10.1016\/0022-510x(92)90067-u PMID: 1431985.","journal-title":"J Neurol Sci"},{"issue":"11","key":"912_CR32","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-002-0896-9","volume":"249","author":"GG Kov\u00e1cs","year":"2002","unstructured":"Kov\u00e1cs GG, Trabattoni G, Hainfellner JA, et al. Mutations of the prion protein gene phenotypic spectrum. J Neurol. 2002;249(11):1567\u201382. https:\/\/doi.org\/10.1007\/s00415-002-0896-9 PMID: 12420099.","journal-title":"J Neurol"},{"key":"912_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213\u201339. https:\/\/doi.org\/10.1093\/bmb\/66.1.213 PMID: 14522861.","journal-title":"Br Med Bull"},{"issue":"4","key":"912_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/v11040309","volume":"11","author":"M Rossi","year":"2019","unstructured":"Rossi M, Baiardi S, Parchi P. Understanding prion strains: evidence from studies of the disease forms affecting humans. Viruses. 2019;11(4):309. https:\/\/doi.org\/10.3390\/v11040309 PMID: 30934971; PMCID: PMC6520670.","journal-title":"Viruses"},{"key":"912_CR35","doi-asserted-by":"publisher","first-page":"20443","DOI":"10.1038\/srep20443","volume":"6","author":"L Pirisinu","year":"2016","unstructured":"Pirisinu L, Di Bari MA, D'Agostino C, et al. Gerstmann-Str\u00e4ussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases. Sci Rep. 2016;6:20443. https:\/\/doi.org\/10.1038\/srep20443 Published 2016 Feb 4. PMID: 26841849; PMCID: PMC4740801.","journal-title":"Sci Rep"},{"issue":"14","key":"912_CR36","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.1073\/pnas.95.14.8322","volume":"95","author":"P Parchi","year":"1998","unstructured":"Parchi P, Chen SG, Brown P, et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Str\u00e4ussler-Scheinker disease. Proc Natl Acad Sci U S A. 1998;95(14):8322\u20137. https:\/\/doi.org\/10.1073\/pnas.95.14.8322 PMID: 9653185; PMCID: PMC20974.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"912_CR37","doi-asserted-by":"publisher","first-page":"e3000725","DOI":"10.1371\/journal.pbio.3000725","volume":"18","author":"EA Asante","year":"2020","unstructured":"Asante EA, Linehan JM, Tomlinson A, et al. Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS. PLoS Biol. 2020;18(6):e3000725. https:\/\/doi.org\/10.1371\/journal.pbio.3000725 PMID: 32516343; PMCID: PMC7282622.","journal-title":"PLoS Biol"},{"key":"912_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.pmbts.2020.08.007","volume":"175","author":"A Mar\u00edn-Moreno","year":"2020","unstructured":"Mar\u00edn-Moreno A, Espinosa JC, Torres JM. Transgenic mouse models for the study of prion diseases. Prog Mol Biol Transl Sci. 2020;175:147\u201377. https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.007 Epub 2020 Sep 11. PMID: 32958231.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"12","key":"912_CR39","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3201\/eid1912.130106","volume":"19","author":"JM Torres","year":"2013","unstructured":"Torres JM, Castilla J, Pintado B, et al. Spontaneous generation of infectious prion disease in transgenic mice. Emerg Infect Dis. 2013;19(12):1938\u201347. https:\/\/doi.org\/10.3201\/eid1912.130106 PMID: 24274622; PMCID: PMC3840888.","journal-title":"Emerg Infect Dis"},{"issue":"32","key":"912_CR40","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1523\/JNEUROSCI.2542-09.2009","volume":"29","author":"W Yang","year":"2009","unstructured":"Yang W, Cook J, Rassbach B, et al. A new transgenic mouse model of Gerstmann-Straussler-Scheinker syndrome caused by the A117V mutation of PRNP. J Neurosci. 2009;29(32):10072\u201380. https:\/\/doi.org\/10.1523\/JNEUROSCI.2542-09.2009 PMID: 19675240; PMCID: PMC2749997.","journal-title":"J Neurosci"},{"issue":"9","key":"912_CR41","doi-asserted-by":"publisher","first-page":"e1003643","DOI":"10.1371\/journal.ppat.1003643","volume":"9","author":"EA Asante","year":"2013","unstructured":"Asante EA, Linehan JM, Smidak M, et al. Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein. PLoS Pathog. 2013;9(9):e1003643. https:\/\/doi.org\/10.1371\/journal.ppat.1003643 Epub 2013 Sep 26. PMID: 24086135; PMCID: PMC3784465.","journal-title":"PLoS Pathog"},{"key":"912_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.arr.2017.03.007","volume":"36","author":"M Senesi","year":"2017","unstructured":"Senesi M, Lewis V, Kim JH, et al. In vivo prion models and the disconnection between transmissibility and neurotoxicity. Ageing Res Rev. 2017;36:156\u201364. https:\/\/doi.org\/10.1016\/j.arr.2017.03.007 Epub 2017 Apr 24. PMID: 28450269.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"912_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/1531-8249(199904)45:4%3c489::aid-ana10%3e3.0.co;2-o","volume":"45","author":"G Forloni","year":"1999","unstructured":"Forloni G, Angeretti N, Malesani P, et al. Influence of mutations associated with familial prion-related encephalopathies on biological activity of prion protein peptides. Ann Neurol. 1999;45(4):489\u201394. https:\/\/doi.org\/10.1002\/1531-8249(199904)45:4%3c489::aid-ana10%3e3.0.co;2-o PMID: 10211473.","journal-title":"Ann Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00912-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00912-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00912-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T23:35:36Z","timestamp":1643585736000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00912-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["912"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00912-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-483825\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"30 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of the Hospital Cl\u00ednic de Barcelona.Animal experiments were conducted in accordance with the Code for Methods and Welfare Considerations in Behavioral Research with Animals (Directive 2010\/63\/EU) and every effort was made to minimize animal suffering. Transmission experiments were developed at Centro de Investigaci\u00f3n en Sanidad Animal (CISA-INIA-CSIC, Madrid, Spain) and they were evaluated by the Committee on the Ethics of Animal Experiments of the Instituto Nacional de Investigaci\u00f3n y Tecnolog\u00eda Agraria y Alimentaria and approved by the General Directorate of the Madrid Community Government (permit nos. PROEX 291\/19 and PROEX 094\/18).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participants or their next-of-kin provided written informed consent for the use of samples for diagnostic and research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RSV reports personal fees from Wave pharmaceuticals and Ionis Pharmaceuticals for attending Advisory board meetings, personal fees from Roche diagnostics, Janssen, and Neuraxpharm for educational activities, and research grants to her institution from Biogen and Sage Therapeutics outside the submitted work. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}